TR201001862A1 - Kontrollü salım gerçekleştiren pramipeksol formülasyonları. - Google Patents

Kontrollü salım gerçekleştiren pramipeksol formülasyonları.

Info

Publication number
TR201001862A1
TR201001862A1 TR2010/01862A TR201001862A TR201001862A1 TR 201001862 A1 TR201001862 A1 TR 201001862A1 TR 2010/01862 A TR2010/01862 A TR 2010/01862A TR 201001862 A TR201001862 A TR 201001862A TR 201001862 A1 TR201001862 A1 TR 201001862A1
Authority
TR
Turkey
Prior art keywords
controlled release
release pramipexole
formulations
pramipexole formulations
pramipexole
Prior art date
Application number
TR2010/01862A
Other languages
English (en)
Inventor
�M�T ��Fter Musa
T�Rkyilmaz Al�
�Ner Levent
Yelken G�Lay
Al� Turp Hasan
Original Assignee
Sanovel �La� San.Ve T�C.A.�.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanovel �La� San.Ve T�C.A.�. filed Critical Sanovel �La� San.Ve T�C.A.�.
Priority to TR2010/01862A priority Critical patent/TR201001862A1/tr
Priority to US13/044,709 priority patent/US20110223245A1/en
Priority to EP11157742.5A priority patent/EP2364694B1/en
Priority to ES11157742.5T priority patent/ES2443583T3/es
Publication of TR201001862A1 publication Critical patent/TR201001862A1/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Buluş, kontrollü salıma sahip bır farmasotik formülasyon olup, pramipeksol veya pramipeksolun farmasotik olarak kabul edilebilir bir tuzu ile kolloidal silikon dioksit ve gliseril behanat içermektedir.
TR2010/01862A 2010-03-11 2010-03-11 Kontrollü salım gerçekleştiren pramipeksol formülasyonları. TR201001862A1 (tr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
TR2010/01862A TR201001862A1 (tr) 2010-03-11 2010-03-11 Kontrollü salım gerçekleştiren pramipeksol formülasyonları.
US13/044,709 US20110223245A1 (en) 2010-03-11 2011-03-10 Controlled-release formulations of pramipexole
EP11157742.5A EP2364694B1 (en) 2010-03-11 2011-03-10 Controlled-release formulations of pramipexole
ES11157742.5T ES2443583T3 (es) 2010-03-11 2011-03-10 Formulaciones de pramipexol de liberación controlada

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2010/01862A TR201001862A1 (tr) 2010-03-11 2010-03-11 Kontrollü salım gerçekleştiren pramipeksol formülasyonları.

Publications (1)

Publication Number Publication Date
TR201001862A1 true TR201001862A1 (tr) 2011-10-21

Family

ID=42736928

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2010/01862A TR201001862A1 (tr) 2010-03-11 2010-03-11 Kontrollü salım gerçekleştiren pramipeksol formülasyonları.

Country Status (4)

Country Link
US (1) US20110223245A1 (tr)
EP (1) EP2364694B1 (tr)
ES (1) ES2443583T3 (tr)
TR (1) TR201001862A1 (tr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE051406T2 (hu) 2012-11-14 2021-03-01 Grace W R & Co Biológiailag aktív anyagot és rendezetlen szervetlen oxidot tartalmazó kompozíciók
CN106474084B (zh) * 2015-08-28 2020-12-11 江苏先声药业有限公司 一种盐酸普拉克索缓释制剂及其制备方法
CN111588692B (zh) * 2020-05-23 2022-11-22 常州市第四制药厂有限公司 盐酸普拉克索口服溶液

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004010999A1 (en) * 2002-07-25 2004-02-05 Pharmacia Corporation Pramipexole once-daily dosage form
WO2007054976A2 (en) * 2005-11-08 2007-05-18 Panacea Biotec Ltd. Lipid based controlled release pharmaceutical composition
WO2007090882A2 (en) * 2006-02-10 2007-08-16 Boehringer Ingelheim International Gmbh Pharmaceutical extended release compositions comprising pramipexole
WO2008129043A1 (en) * 2007-04-24 2008-10-30 Boehringer Ingelheim International Gmbh Combination with an extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof
EP2135602A1 (en) * 2004-08-13 2009-12-23 Boehringer Ingelheim International GmbH Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE45735T1 (de) 1984-12-22 1989-09-15 Thomae Gmbh Dr K Tetrahydro-benzthiazole, deren herstellung und deren verwendung als zwischenprodukte oder als arnzneimittel.
US20050226926A1 (en) 2002-07-25 2005-10-13 Pfizer Inc Sustained-release tablet composition of pramipexole
US7671094B2 (en) * 2005-06-27 2010-03-02 Biovail Laboratories International S.R.L. Bupropion hydrobromide and therapeutic applications
US20090004281A1 (en) * 2007-06-26 2009-01-01 Biovail Laboratories International S.R.L. Multiparticulate osmotic delivery system

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004010999A1 (en) * 2002-07-25 2004-02-05 Pharmacia Corporation Pramipexole once-daily dosage form
EP2135602A1 (en) * 2004-08-13 2009-12-23 Boehringer Ingelheim International GmbH Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof
WO2007054976A2 (en) * 2005-11-08 2007-05-18 Panacea Biotec Ltd. Lipid based controlled release pharmaceutical composition
WO2007090882A2 (en) * 2006-02-10 2007-08-16 Boehringer Ingelheim International Gmbh Pharmaceutical extended release compositions comprising pramipexole
WO2008129043A1 (en) * 2007-04-24 2008-10-30 Boehringer Ingelheim International Gmbh Combination with an extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof

Also Published As

Publication number Publication date
US20110223245A1 (en) 2011-09-15
EP2364694B1 (en) 2013-11-06
EP2364694A1 (en) 2011-09-14
ES2443583T3 (es) 2014-02-19

Similar Documents

Publication Publication Date Title
CY1125100T1 (el) Υδατικο φαρμακευτικο σκευασμα ταπενταδολης για απο του στοματος χορηγηση
CY1124007T1 (el) Στοματικες δοσολογικες μορφες παρατεταμενης απελευθερωσης τοφασιτινιμπης
MY163083A (en) Solid forms of a pharmaceutically active substance
TWD186769S (zh) 口腔保健用具之包裝盒（三）
BR112013004016A2 (pt) formulações á base de nalbufina e as respectivas utilizações
MX2011011109A (es) Formulaciones orales de bendamustina.
MX347105B (es) Composiciones farmaceuticas que comprenden hidromorfona y naloxona.
CR20150266A (es) Formulaciones de liberación modificada para oprozomib
MX344846B (es) Combinacion de granulos cargados activos con activos adicionales.
EP3500291A4 (en) FORMULATIONS FOR THE ORAL ADMINISTRATION OF ACTIVE AGENTS
EA201291104A1 (ru) Пероральные лекарственные формы бендамустина
DE602005025767D1 (de) Orale tedisamilformulierungen mit magenretentionseigenschaften und verzögerter freisetzung
TR201009394A2 (tr) Geliştirilmiş montelukast formülasyonları.
TR201001862A1 (tr) Kontrollü salım gerçekleştiren pramipeksol formülasyonları.
TR200909613A1 (tr) Pregabalinin farmasötik bileşimleri.
TR201007926A1 (tr) Prasugrel tablet formülasyonları.
TR201721700A2 (tr) Saksagli̇pti̇ni̇n ağizda dağilan formülasyonlari
EA201201329A1 (ru) Новая композиция для лечения эссенциальной тромбоцитемии
TR201005241A1 (tr) Kontrollü salım sağlayan pregabalin solüsyon formülasyonu.
TR201009399A2 (tr) Hızlı çözünen efervesan rosuvastatin formülasyonları.
EA201500367A1 (ru) Фармацевтическая композиция 1-адамантилетилокси-3-морфолино-2-пропанола или его фармацевтически приемлемых солей для лечения цереброваскулярной патологии и нейродегенеративных заболеваний центральной нервной системы
TR201101809A1 (tr) Vildagliptin ve glimepirid kombinasyonları.
TR201008460A1 (tr) Eslikarbazepinin saşe formülasyonları.
TN2014000484A1 (en) Dronedarone for use in leishmaniasis, formulations and associations for use in leishmaniasis.
TR201002256A1 (tr) Stabil aliskiren formülasyonları